The United Kingdom's biologics market encompasses diverse therapeutic categories addressing varied disease states through distinct mechanisms of action and administration routes. The UK Biologics Market segment classification reveals oncology as the dominant therapeutic area, with monoclonal antibodies, immune checkpoint inhibitors, antibody-drug conjugates, and cancer vaccines...